Yang Q, Graham TE, Mody N, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes[J]. Nature, 2005, 436(7049): 356-362.
[3]
Cho YM, Youn BS, Lee H, et al. Plasma retinol binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type2 diabetes[J]. Diabetes Care, 2006, 29(11): 2457-2461.
[4]
Qi Q, Yu Z, Ye X, et al. Elevated retinol2binding p rotein 4 levels are associated with metabolic syndrome in chinese people[J]. J Clin Endocrinol Metab, 2007, 92(12): 4827-4834.
[5]
von Eynatten M, Lepper PM, Liu D, et al. Retinol binding protein 4 is associated with components of the metabolic syndrome, but notwith insulin resistance, in men with type 2 diabetes or coronary artery disease[J].Diabetologia, 2007, 50(9): 1930-1937.
[6]
Cabré A, Lázaro I, Girona J, et al. Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes[J].J Intern Med, 2007, 262(4): 496-503.
Lee JW, Im JA, Lee HR, et al. Visceral adiposity is associated with serum retinol binding protein-4 levels in healthy women[J]. Obesity(Silver Spring), 2007, 15(9): 2225-2232.
[10]
Yao-Borengasser A, Varma V, Bodles AM, et al. Retinol binding protein 4 expression in humans:relationship to insulin resistance, inflammation, and response to pioglitazone[J]. J Clin Endocrinol Metab, 2007, 92(7): 2590-2597.
Perseghin G, Lattuada G, De Cobelli F, et al. Serum retinol-binding protein-4, leptin, and adiponectin concentrations are related to ectopic fat accumulation[J]. J Clin Endocrinol Metab, 2007, 92(12): 4883-4888.